A Q&A with Jamie Clayton of Freeman Technology What is dynamic powder testing and why is it valuable for DPI development? Dynamic powder testing is a modern technique developed specifically to generate process relevant powder properties where dynamic powder properties, including basic flowability energy (BFE) and specific energy (SE), are generated from … [Read more...] about Using dynamic powder testing in DPI development
Features
RDD Europe 2019 to address Brexit and other hot topics
RDD Europe 2019 will take place May 7-10 at the Estoril Congress Center outside of Lisbon. Organizers expect approximately 500 inhaled and nasal drug specialists from industry, academia, and regulatory agencies to attend this year's meeting. Richard Dalby of RDD Online, which co-organizes the meeting with Aptar Pharma, notes that one of the current hot topics of … [Read more...] about RDD Europe 2019 to address Brexit and other hot topics
RDD Europe workshop topics: new propellant, devices, and tech
One of the distinguishing features of RDD Europe is the workshop session, when a dozen companies offer 60-minute presentations on their latest technology, products, or services to small groups of 10-40 people at a time. Each workshop is presented 3 times during the session, and RDD Europe attendees have the opportunity to select 3 of the 12 sessions. "The … [Read more...] about RDD Europe workshop topics: new propellant, devices, and tech
DDL 2018 in review
The annual Drug Delivery to the Lungs meeting once again experienced significant growth in attendance and sponsorship, as DDL 2018 drew more than 850 attendees and 110 exhibitors to the Edinburg International Conference Centre. Many of the talks focused on the need for OINDP specialists to better deal with the complexity inherent in aerosol drug delivery and to … [Read more...] about DDL 2018 in review
DDL 2018 expected to be the biggest Drug Delivery to the Lungs meeting yet
Organizers of DDL 2018 say that they are expecting over 800 OINDP specialists to attend this year's iteration of the Drug Delivery to the Lungs meeting, to be held December 12-14 in Edinburgh, UK. According to DDL 2018 committee members Phil Haywood and David Harris, the exhibition hall has been reconfigured to allow up to 100 companies to introduce their latest … [Read more...] about DDL 2018 expected to be the biggest Drug Delivery to the Lungs meeting yet
Igor Gonda: Cloud medicine is not just a pie in the sky for OINDPs
I am sure that I was not alone to conclude after the 2018 Respiratory Drug Delivery Conference that the most profoundly important session was “Exploring the Benefits of Smart Inhalers on Public Health.” And I immediately thought about the ambitions we had at Aradigm Corporation for our SmartMist device – the first “electronic inhaler.” Smartmist was really smart: … [Read more...] about Igor Gonda: Cloud medicine is not just a pie in the sky for OINDPs
Highlights from RDD 2018
Approximately 550 OINDP specialists attended RDD 2018 in Tucson, Arizona, where much of the interest centered around regulatory issues, especially in light of the FDA's recent release of a revised draft guidance on MDI and DPI quality considerations. The RDD organizers capitalized on the release, adding a late breaking presentation by the FDA's Rik Lostritto on … [Read more...] about Highlights from RDD 2018
Copley Scientific’s Mark Copley answers questions about USP Chapter <1602>
Copley Scientific CEO Mark Copley discusses the recently published USP Chapter <1602> for testing "Spacers & Valved Holding Chambers Used with Inhalation Aerosols" Q: What does this new USP Chapter cover? A: Chapter <1602>, published by the United States Pharmacopeia (USP) in 2017, defines standardized methods for characterizing the in vitro … [Read more...] about Copley Scientific’s Mark Copley answers questions about USP Chapter <1602>
RDD 2018 set to explore hot topics in Tucson
The upcoming RDD 2018 meeting, which will take place April 22-26 in Tucson, AZ, features a program designed to address many of the most pressing questions for OINDP developers today, along with extensive poster and technology exhibitions and a week full of networking opportunities. The RDD 2018 program sessions include: • Frontiers in Lung Biology • Exploring the … [Read more...] about RDD 2018 set to explore hot topics in Tucson
FDA workshop offers insights on OINDP development and BE assessment
By Lei Zhang, PhD, Deputy Director, Office of Research and Standards The FDA’s Center for Drug Evaluation and Research, Office of Generic Drugs (OGD), Office of Research and Standards, Division of Therapeutic Performance has made great strides in new approaches that demonstrate therapeutic equivalence for locally-acting orally-inhaled and nasal drug products … [Read more...] about FDA workshop offers insights on OINDP development and BE assessment